+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Dovonex"

Psoriasis Market and Forecast Analysis to 2025 - Product Thumbnail Image

Psoriasis Market and Forecast Analysis to 2025

  • Drug Pipelines
  • July 2018
  • 616 Pages
  • Global
From
  • 1 Results (Page 1 of 1)
Loading Indicator

Dovonex is a topical medication used to treat psoriasis, a chronic skin condition characterized by red, scaly patches. It is a vitamin D3 analog, which works by slowing the growth of skin cells and reducing inflammation. Dovonex is available in both cream and ointment form, and is typically applied to affected areas twice daily. It is generally well-tolerated, but may cause skin irritation or burning in some patients. The psoriasis drug market is a rapidly growing segment of the pharmaceutical industry. It is estimated that the global psoriasis drug market will reach $14.5 billion by 2027. Dovonex is one of the most commonly prescribed medications for psoriasis, and is used by millions of patients worldwide. Some of the companies in the Dovonex market include Galderma, Sun Pharmaceuticals, and Mylan. Show Less Read more